[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@Biopharma_Watch](/creator/twitter/Biopharma_Watch)
"$GKOS 83.69$ -XXXX% October XX 2025 Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting"  
[X Link](https://x.com/Biopharma_Watch/status/1978487338813808952) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-15T15:45Z 1135 followers, XXX engagements


"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $XRTX - 2.7M - 78.9M - XXXXX $RANI - 8.0M - 230.1M - XXXXX $ARTV - 2.7M - 55.5M - 20.78"  
[X Link](https://x.com/Biopharma_Watch/status/1979212073365311895) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XXX engagements


"Top Market Movers: Positive News Full Access: $RANI 2.15$ XXXXX% October XX 2025 Rani Therapeutics Announces up to $XXXXX Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including R"  
[X Link](https://x.com/Biopharma_Watch/status/1980299231576666219) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-20T15:45Z 1135 followers, XXX engagements


"Top Market Movers: Negative News Full Access: $ARTL 4.75$ -XXXXX% September XX 2025 Artelo Biosciences Announces Presentation of Positive Interim Phase X CAReS Data on ART27.13 at the 2025 Cancer Cachexia Society Conference"  
[X Link](https://x.com/Biopharma_Watch/status/1973051475686494652) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-09-30T15:45Z 1133 followers, XXX engagements


"Top Market Movers: Negative News Full Access: $GTBP 0.74$ -XXXXX% October X 2025 GT Biopharma Provides Enrollment Update on GTB-3650 Phase X Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Ma"  
[X Link](https://x.com/Biopharma_Watch/status/1976312963482153034) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-09T15:45Z 1133 followers, XXX engagements


"Latest catalysts: $TNXP Catalyst Date - 2025-10-15 Drug - TNX-801 (Mpox Vaccine) Treatment - Mpox Smallpox"  
[X Link](https://x.com/Biopharma_Watch/status/1978487293045510608) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-15T15:45Z 1133 followers, XXX engagements


"$IOBT Catalyst Date - 2025-10-17 Drug - Cylembio (imsapepimut and etimupepimut adjuvanted) Treatment - advanced melanoma advanced solid tumors"  
[X Link](https://x.com/Biopharma_Watch/status/1978487338495001020) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-15T15:45Z 1134 followers, XXX engagements


"Latest catalysts: $OCUL Catalyst Date - 2025-10-16 Drug - AXPAXLI (OTX-TKI) Treatment - wet age-related macular degeneration (wet AMD)"  
[X Link](https://x.com/Biopharma_Watch/status/1978849683817816524) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-16T15:45Z 1133 followers, XXX engagements


"$IOBT Catalyst Date - 2025-10-17 Drug - Cylembio (imsapepimut and etimupepimut adjuvanted) Treatment - advanced melanoma advanced solid tumors"  
[X Link](https://x.com/Biopharma_Watch/status/1978849701761065232) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-16T15:45Z 1134 followers, XXX engagements


"$IOBT Catalyst Date - 2025-10-17 Drug - Cylembio (imsapepimut and etimupepimut adjuvanted) Treatment - Squamous cell carcinoma of head and neck (SCCHN)"  
[X Link](https://x.com/Biopharma_Watch/status/1978849716428587171) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-16T15:45Z 1133 followers, XXX engagements


"Top Market Movers: Negative News Full Access: $RCEL 3.95$ -XXXXX% October XX 2025 AVITA Medical Announces CEO Transition"  
[X Link](https://x.com/Biopharma_Watch/status/1979212071897292925) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XXX engagements


"$OMER 8.15$ -XXXXX% October XX 2025 Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group"  
[X Link](https://x.com/Biopharma_Watch/status/1979212073168179709) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1134 followers, XX engagements


"$LLY Catalyst Date - 2025-10-17 Drug - Verzenio (abemaciclib; CDK4/6 inhibitor) Treatment - HR+HER2- node-positive high-risk early breast cancer"  
[X Link](https://x.com/Biopharma_Watch/status/1979212101718806897) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1133 followers, XXX engagements


"Top Market Movers: Negative News Full Access: $BRKR 29.35$ -XXXXX% September X 2025 Bruker Announces Pricing of Public Offering of $XXX Million of XXXXX% Mandatory Convertible Preferred Stock"  
[X Link](https://x.com/Biopharma_Watch/status/1963597430433120468) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-09-04T13:38Z 1135 followers, XXX engagements


"Top Market Movers: Negative News Full Access: $ACTU 6.97$ -XXXXX% September XX 2025 Actuate Therapeutics Announces Proposed Public Offering of Common Stock"  
[X Link](https://x.com/Biopharma_Watch/status/1965803717229502904) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-09-10T15:45Z 1135 followers, XXX engagements


"$PFE 26.98$ XXXX% October XX 2025 Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025"  
[X Link](https://x.com/Biopharma_Watch/status/1973413886855618891) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-01T15:45Z 1135 followers, XX engagements


"Latest catalysts: $STTK Catalyst Date - 2025-10-08 Drug - SL-325 (Death Receptor X blocking antibody) Treatment - Inflammatory bowel disease (IBD) inflammatory and immune-related diseases"  
[X Link](https://x.com/Biopharma_Watch/status/1975588187369255290) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-07T15:45Z 1135 followers, XXX engagements


"Latest catalysts: $STTK Catalyst Date - 2025-10-08 Drug - SL-325 (Death Receptor X blocking antibody) Treatment - Inflammatory bowel disease (IBD) inflammatory and immune-related diseases"  
[X Link](https://x.com/Biopharma_Watch/status/1975950576883286148) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-08T15:45Z 1135 followers, XXX engagements


"$DYN Catalyst Date - 2025-10-08 Drug - zeleciment basivarsen (z-basivarsen formerly known as DYNE-101) Treatment - myotonic dystrophy type X (DM1)"  
[X Link](https://x.com/Biopharma_Watch/status/1975950589998907721) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-08T15:45Z 1135 followers, XX engagements


"Latest catalysts: $SGMT Catalyst Date - 2025-10-09 Drug - denifanstat (selective FASN inhibitor) Treatment - metabolic dysfunction associated steatohepatitis (MASH)"  
[X Link](https://x.com/Biopharma_Watch/status/1976312964266459389) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-09T15:45Z 1135 followers, XXX engagements


"$LYRA Catalyst Date - 2025-10-11 Drug - LYR-210 (mometasone furoate) Treatment - Chronic rhinosinusitis (CRS)"  
[X Link](https://x.com/Biopharma_Watch/status/1976312990740918518) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-09T15:45Z 1135 followers, XX engagements


"Top Market Movers: Negative News Full Access: $APM 1.69$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives"  
[X Link](https://x.com/Biopharma_Watch/status/1976675349451903424) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-10T15:45Z 1135 followers, XXX engagements


"Latest catalysts: $RVPH Catalyst Date - 2025-10-10 Drug - brilaroxazine (RP5063) Treatment - schizophrenia"  
[X Link](https://x.com/Biopharma_Watch/status/1976675350945104223) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-10T15:45Z 1135 followers, XXX engagements


"$LYRA Catalyst Date - 2025-10-11 Drug - LYR-210 (mometasone furoate) Treatment - Chronic rhinosinusitis (CRS)"  
[X Link](https://x.com/Biopharma_Watch/status/1976675364224311702) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-10T15:45Z 1135 followers, XXX engagements


"$APM 1.45$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives"  
[X Link](https://x.com/Biopharma_Watch/status/1977762531327496532) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-13T15:45Z 1135 followers, XX engagements


"Top Market Movers: Positive News Full Access: $ANVS 2.16$ XXXXX% October XX 2025 Annovis Announces Closing of $X Million Registered Direct Offering of Common Stock"  
[X Link](https://x.com/Biopharma_Watch/status/1978849678491025832) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-16T15:45Z 1135 followers, XXX engagements


"$SYRE 23.30$ XXXX% October XX 2025 Spyre Therapeutics Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $XXXXX Million"  
[X Link](https://x.com/Biopharma_Watch/status/1978849708924932243) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-16T15:45Z 1135 followers, XX engagements


"$AVTR 14.48$ XXXX% October XX 2025 Avantor and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology"  
[X Link](https://x.com/Biopharma_Watch/status/1978849726092177864) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-16T15:45Z 1135 followers, XXX engagements


"Top Market Movers: Positive News Full Access: $ARTV 5.46$ XXXXX% October XX 2025 Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication Upcoming Data Releases and Corporate Update"  
[X Link](https://x.com/Biopharma_Watch/status/1979212068462235696) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XXX engagements


"Latest catalysts: $IOBT Catalyst Date - 2025-10-17 Drug - Cylembio (imsapepimut and etimupepimut adjuvanted) Treatment - advanced melanoma advanced solid tumors"  
[X Link](https://x.com/Biopharma_Watch/status/1979212072673251532) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XXX engagements


"$IRON 89.61$ XXXXX% October XX 2025 Disc Medicine Announces Receipt of FDA Commissioners National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)"  
[X Link](https://x.com/Biopharma_Watch/status/1979212079086342462) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XX engagements


"$PRAX 183.28$ XXXXX% October XX 2025 Praxis Precision Medicines Inc. Announces Pricing of $XXX Million Public Offering"  
[X Link](https://x.com/Biopharma_Watch/status/1979212092625568164) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XX engagements


"$AGIO 42.50$ XXXX% October XX 2025 Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October XX at 8:00 a.m. ET"  
[X Link](https://x.com/Biopharma_Watch/status/1979212105065886094) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XXX engagements


"$TSHA 4.50$ -XXXXX% October XX 2025 Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome"  
[X Link](https://x.com/Biopharma_Watch/status/1979212118504411224) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-17T15:45Z 1135 followers, XXX engagements


"Latest catalysts: $RNXT Catalyst Date - 2025-09-16 Drug - RenovoCath (intra-arterial gemcitabine delivered via RenovoCath known as IAG) Treatment - locally advanced pancreatic cancer (LAPC)"  
[X Link](https://x.com/Biopharma_Watch/status/1967978045727514710) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-09-16T15:45Z 1135 followers, XXX engagements


"Top Market Movers: Positive News Full Access: $ADXN 10.17$ XXXXX% September XX 2025 Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update"  
[X Link](https://x.com/Biopharma_Watch/status/1973051471601205324) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-09-30T15:45Z 1135 followers, XXX engagements


"Top Market Movers: Negative News Full Access: $XRTX 0.80$ -XXXXX% October XX 2025 XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems"  
[X Link](https://x.com/Biopharma_Watch/status/1980299235703820620) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-20T15:45Z 1135 followers, XXX engagements


"Latest catalysts: $BCTX Catalyst Date - 2025-10-20 Drug - Bria-IMT Treatment - Advanced Metastatic Breast Cancer"  
[X Link](https://x.com/Biopharma_Watch/status/1980299237217988612) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-20T15:45Z 1135 followers, XXX engagements


"$GMAB 31.11$ -XXXX% October XX 2025 Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer"  
[X Link](https://x.com/Biopharma_Watch/status/1980299265089163284) [@Biopharma_Watch](/creator/x/Biopharma_Watch) 2025-10-20T15:45Z 1135 followers, XXX engagements